Read + Share
Metts J, Harrington B, Salman E, Bradfield SM, et al. A phase I study of irinotecan and temozolomide with bevacizumab in children with
recurrent/refractory central nervous system tumors. Childs Nerv Syst 2022;38:919-928.
PMID: 35260913
|
 |
|
Metts J, Harrington B, Salman E, Bradfield SM, et al. A phase I study of irinotecan and temozolomide with bevacizumab in children with
recurrent/refractory central nervous system tumors. Childs Nerv Syst 2022;38:919-928.
PMID: 35260913
|
|
|
|